India approves Gilead's remdesivir to treat severe COVID-19 cases

India's government has approved Gilead Sciences Inc's antiviral drug remdesivir for emergency use for five doses in treating COVID-19 patients.

from Reuters: Health News https://ift.tt/3dwMoGY
via IFTTT